Clinical trialNCT00516399TerminatedPhase 3Interventional

A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine

SponsorUniversity of California, Los AngelesEnrollment78Fungal Keratitis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine the effectiveness of 1.25% povidone-iodine ophthalmic solution for the treatment of small to medium sized fungal corneal ulcers compared with an antifungal antibiotic.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Sherwin J. Isenberg, M.D.
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Natamycin →Povidone-iodine 1.25% ophthalmic solution

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Mar 2008
Primary completion: 30 Sept 2010
Completion: 31 Dec 2010
Last update posted: 4 Dec 2014
Registered enrollment: 78
Registry id: NCT00516399

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.